Search

everythinglearnresearchcommunity

for

Search:↓

The DLQI is a key tool for measuring quality of life in dermatology.

Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Microneedle Treatment System is effective for hair growth and skin improvement with no serious side effects, but more research is needed.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Stem cell treatment improved life quality and sexual function in women with hair loss.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Hair loss in alopecia areata can negatively affect sexual quality of life.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Vitiligo causes significant emotional stress in Africa, the Middle East, and Latin America, with limited treatment options available.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Alopecia areata affects quality of life more than androgenetic alopecia.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.

AGA patients have a lower quality of life than AA patients.

More severe hair loss worsens quality of life in men.

Androgenetic alopecia affects men's emotions more than symptoms or daily function.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Baricitinib is an effective treatment for severe alopecia areata.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

The study concludes that Loose Anagen Hair Syndrome is a benign condition that usually improves with age but can be hard to diagnose and stressful for the family.